Shields, Alan L.
Lamoureux, Roger E.
Taylor, Fiona
Barth, Jay A.
Mulberg, Andrew E.
Kessler, Vivian
Skuban, Nina
Funding for this research was provided by:
Amicus Therapeutics, Inc.
Article History
Accepted: 12 April 2021
First Online: 29 April 2021
Declarations
:
: Alan L. Shields, Roger E. Lamoureux, and Fiona Taylor are employees of Adelphi Values, which provides research services to pharmaceutical drug development companies including Amicus Therapeutics, Inc. Vivian Kessler is an employee of and stockholder in Amicus Therapeutics, Inc. Jay A. Barth, Andrew E. Mulberg, and Nina Skuban are former employees of Amicus Therapeutics, Inc., and hold stock in Amicus Therapeutics, Inc.
: Study procedures were approved by the Copernicus Group Independent Review Board (Durham, NC, USA).
: All patients provided written informed consent.
: All authors provided consent for the publication of this work.